{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T03:38:04Z","timestamp":1787283484242,"version":"build-2736575974"},"reference-count":27,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:sec id=\"ab-eoi260033-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Hypertension is a major modifiable risk factor for diabetic retinopathy progression but may not be assessed routinely during ophthalmology visits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260033-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate prevalence of elevated or uncontrolled blood pressure (BP) among adults with diabetes presenting for ophthalmologic care and patient attitudes toward in-clinic screening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260033-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This prospective case series was conducted from July 2024 to August 2024 at a single academic retina clinic. Data were analyzed from October 2025 to December 2025. Adults aged 18 years or older with type 1 or type 2 diabetes underwent in-clinic BP measurement and completed a structured survey on hypertension history, monitoring, perceived control, and knowledge. Additional clinical and ophthalmic data were obtained from electronic medical records.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260033-7\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was the prevalence of elevated BP and hypertension stage by 2017 American College of Cardiology\/American Heart Association criteria, in which classification depends on both systolic and diastolic values. Normal BP was defined as systolic BP less than 120 mm Hg and diastolic BP less than 80 mm Hg; elevated, systolic BP 120 to 129 mm Hg and diastolic BP less than 80 mm Hg; stage 1 hypertension, systolic BP 130 to 139 mm Hg or diastolic BP 80 to 89 mm Hg; stage 2 hypertension, systolic BP of 140 mm Hg or higher or diastolic BP of 90 mm Hg or higher; and hypertensive crisis, systolic BP higher than 180 mm Hg and\/or diastolic BP higher than 120 mm Hg.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260033-8\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 172 patients (mean [SD] age, 66.6 [13.9] years; 84 female patients [48.8%]), 14 (8.1%) had normal blood pressure, 91 (52.9%) had stage 2 hypertension, and 18 (10.5%) met criteria for hypertensive crisis. A prior diagnosis of hypertension was present in 144 of 172 patients (83.7%); among these, 131 of 144 patients (91.0%) were receiving antihypertensive therapy. Among 28 patients without known hypertension, 24 of 28 (85.7%) had above-normal blood pressure, including 10 of 28 (35.7%) with stage 2 hypertension and 3 of 28 (10.7%) in hypertensive crisis. Although 100 of 144 patients with diagnosed hypertension (69.4%) perceived their control as good or excellent, 115 (79.9%) had BP stage 1 or greater. Following measurement, 103 of 172 patients (59.9%) were advised to contact their primary care clinician, and 20 of 172 (11.6%) required expedited follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260033-9\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this single-center case series, uncontrolled or previously unrecognized hypertension was highly prevalent among patients with diabetes, even among those engaged in routine medical follow-up. Opportunistic BP screening in ophthalmology clinics appears feasible and may identify actionable cardiovascular risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2026.2245","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:30:40Z","timestamp":1782401440000},"page":"705","source":"Crossref","is-referenced-by-count":1,"title":["Blood Pressure Assessment in Ophthalmology Clinics for Patients With Diabetes"],"prefix":"10.1001","volume":"144","author":[{"given":"Sai","family":"Samayamanthula","sequence":"first","affiliation":[{"name":"University of Virginia School of Medicine, Charlottesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Virginia, Charlottesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Markowski","sequence":"additional","affiliation":[{"name":"University of Virginia School of Medicine, Charlottesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Nguyen","sequence":"additional","affiliation":[{"name":"University of Virginia School of Medicine, Charlottesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Wan","sequence":"additional","affiliation":[{"name":"University of Virginia School of Medicine, Charlottesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adarsh","family":"Mallepally","sequence":"additional","affiliation":[{"name":"Virginia Commonwealth University School of Medicine, Richmond"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Yates","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Virginia, Charlottesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Cusick","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Virginia, Charlottesville"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9735","key":"eoi260033r1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy.","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"eoi260033r2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/ceo.12905","article-title":"Hypertensive eye disease: a review.","volume":"45","author":"Fraser-Bell","year":"2017","journal-title":"Clin Exp Ophthalmol"},{"issue":"7160","key":"eoi260033r3","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38.","volume":"317","author":"UK Prospective Diabetes Study Group","year":"1998","journal-title":"BMJ"},{"issue":"10","key":"eoi260033r4","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1007\/s00125-009-1457-x","article-title":"Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial.","volume":"52","author":"Beulens","year":"2009","journal-title":"Diabetologia"},{"issue":"3","key":"eoi260033r5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006127.pub3","article-title":"Blood pressure control for diabetic retinopathy.","volume":"3","author":"Do","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"eoi260033r6","first-page":"475","article-title":"Risk factors for diabetic retinopathy: findings from the Andhra Pradesh Eye Disease Study.","volume":"1","author":"Krishnaiah","year":"2007","journal-title":"Clin Ophthalmol"},{"issue":"9","key":"eoi260033r7","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1136\/bjo.83.9.1083","article-title":"Hypertension and diabetic retinopathy\u2013what\u2019s the story?","volume":"83","author":"Gillow","year":"1999","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"eoi260033r8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229665","article-title":"Hypertension, blood pressure control and diabetic retinopathy in a large population-based study.","volume":"15","author":"Liu","year":"2020","journal-title":"PLoS One"},{"issue":"6","key":"eoi260033r9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1167\/tvst.13.6.8","article-title":"Hypertension likely drives arteriolar wall thickening in preclinical diabetic retinopathy while diabetes drives wall thickness in clinical retinopathy.","volume":"13","author":"Huang","year":"2024","journal-title":"Transl Vis Sci Technol"},{"issue":"6","key":"eoi260033r10","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00592-017-0974-1","article-title":"The English National Screening Programme for Diabetic Retinopathy 2003-2016.","volume":"54","author":"Scanlon","year":"2017","journal-title":"Acta Diabetol"},{"issue":"10","key":"eoi260033r11","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.ophtha.2018.04.007","article-title":"Guidelines on diabetic eye care: the International Council of Ophthalmology recommendations for screening, follow-up, referral, and treatment based on resource settings.","volume":"125","author":"Wong","year":"2018","journal-title":"Ophthalmology"},{"issue":"4","key":"eoi260033r12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S2213-8587(19)30411-5","article-title":"Screening for diabetic retinopathy: new perspectives and challenges.","volume":"8","author":"Vujosevic","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"eoi260033r13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252321","article-title":"General health of patients with diabetic macular edema-the LIPSIA study.","volume":"16","author":"Busch","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"eoi260033r14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/ajh\/hpy103","article-title":"Uncontrolled hypertension is common in glaucoma clinics.","volume":"32","author":"Varadaraj","year":"2019","journal-title":"Am J Hypertens"},{"issue":"1","key":"eoi260033r15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ajo.2010.08.047","article-title":"Appropriate use and reporting of uncontrolled case series in the medical literature.","volume":"151","author":"Kempen","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"eoi260033r16","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"issue":"3","key":"eoi260033r17","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/sj.eye.6701480","article-title":"Is measurement of blood pressure worthwhile in the diabetic eye clinic?","volume":"19","author":"Al-Husainy","year":"2005","journal-title":"Eye (Lond)"},{"issue":"6","key":"eoi260033r18","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/sj.eye.6702307","article-title":"Blood pressure control in type II diabetics with diabetic retinopathy.","volume":"21","author":"Sivaprasad","year":"2007","journal-title":"Eye (Lond)"},{"issue":"1","key":"eoi260033r19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1464-5491.2008.02614.x","article-title":"Blood pressure control and awareness among patients with diabetes and hypertension attending a tertiary ophthalmic clinic.","volume":"26","author":"Wong","year":"2009","journal-title":"Diabet Med"},{"issue":"11","key":"eoi260033r20","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.optm.2005.08.021","article-title":"Blood pressure control in an African American sample with diabetes mellitus in an urban eye clinic.","volume":"76","author":"Teitelbaum","year":"2005","journal-title":"Optometry"},{"issue":"38","key":"eoi260033r21","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012185","article-title":"Ambulatory blood pressure monitoring and diabetes complications: targeting morning blood pressure surge and nocturnal dipping.","volume":"97","author":"Najafi","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"eoi260033r22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/medicina61101801","article-title":"Effect of circadian blood pressure variations on retinal microvascular structures: optical coherence tomography angiography analysis with the nighttime divided into subintervals (retinal dawn pattern).","volume":"61","author":"Zengin","year":"2025","journal-title":"Medicina (Kaunas)"},{"issue":"5","key":"eoi260033r23","doi-asserted-by":"publisher","first-page":"281","DOI":"10.62347\/DFSZ9202","article-title":"Visit-to-visit variability of blood pressure and risk of diabetic retinopathy: a systematic review and meta-analysis.","volume":"14","author":"Noroozi","year":"2024","journal-title":"Am J Cardiovasc Dis"},{"issue":"1","key":"eoi260033r24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1001\/jamaophthalmol.2018.4892","article-title":"Association of intravitreal injections with blood pressure increase: the Following Excitement and Anxiety Response Under Intravitreal Injection Study.","volume":"137","author":"Berger","year":"2019","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"eoi260033r25","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/0002-9394(85)90229-6","article-title":"Systemic absorption and cardiovascular effects of phenylephrine eyedrops.","volume":"99","author":"Kumar","year":"1985","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"eoi260033r26","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1001\/jamaophthalmol.2015.0325","article-title":"Cardiovascular adverse effects of phenylephrine eyedrops: a systematic review and meta-analysis.","volume":"133","author":"Stavert","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"eoi260033r27","first-page":"971","article-title":"Hypertension screening in the eye clinic.","volume":"16","author":"Baker","year":"1984","journal-title":"Ann Ophthalmol"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2850929\/jamaophthalmology_samayamanthula_2026_oi_260033_1787172282.7007.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:02:06Z","timestamp":1787238126000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2850929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2026.2245","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,1]]}}}